Changzhou radius Pharmaceutical Co., Ltd. was originally Jiangyin Fangyuan Pharmaceutical Co., Ltd., founded in 1994. 2000 moved to Changzhou National High-tech Industrial Development Zone. At present, the company has become a national key high-tech enterprises, high-tech enterprises in Jiangsu Province.
The company is a new generation of semi-synthetic aminoglycoside antibiotics with high efficiency, low toxicity and anti-drug resistance. It is a new class of antibiotics with independent intellectual property rights. And other advantages, and has been China, Britain, the United States, Russia, Kazakhstan, Japan and other national patents. In 2002 the product was named the second prize of national scientific and technological progress, Jiangsu Province Science and Technology Progress Award.
"Let the drug to serve the people, with innovative achievements radius." Company to market-oriented, innovation as the driving force to the quality of the center, is committed to doing fine and stronger enterprises to do so, so that it has a strong ability to develop innovative and counter-risk ability of high-quality enterprises.
To meet the growing market demand and the industrialization of new products, the company decided in Inner Mongolia Chifeng City Yuanbaoshan Industrial Park, 301 acres of land for the migration of raw materials production workshop, expansion and technological transformation. In March 2015, Inner Mongolia Puyin Pharmaceutical Technology Co., Ltd. was established.
The total construction area of 134631 m2, including the production workshop, fermentation and refining workshop, warehouse, "three wastes" processing center, quality inspection research and development building, office building and other supporting facilities, with an annual output of 22.25 tons of raw materials The scale of production of drugs.
Companies with regional bio-pharmaceutical industry development plan, optimize the product structure, improve the quality of pharmaceutical products, Changzhou Life and Health Industrial Park, 197 acres of land to build a new plant.
The new plant is divided into two phases of construction, an area of 96 acres, construction area of 53000m2. The first phase of the project draws on the international advanced experience, guided by the 2010 GMP requirements, in the process technology, purification, energy saving, control, environmental protection, fire and other aspects of a comprehensive optimization, significantly enhance the level of production automation and efficiency, reducing energy consumption and Labor intensity, in order to further enhance the quality of products laid a solid foundation.
At present, three small-capacity injection workshop and a freeze-dried powder injection workshop through the national GMP certification, small capacity injection capacity of 6000 ~ 80 million / year, freeze-dried powder injection was 600 million bottles / year.